Abstract
Vaginal group B streptococcus (GBS) and Escherichia coli isolates were tested for their susceptibilities to ampicillin. All 414 GBS isolates tested were susceptible to ampicillin; the MIC at which 90% of the isolates were inhibited (MIC90) was 0.125 microg/ml, and the range was 0.06 to 0.25 microg/ml. The MIC50 for the 342 E. coli isolates tested was 4.0 microg/ml, and 27% were resistant to ampicillin.
Full Text
The Full Text of this article is available as a PDF (212.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amstey M. S., Gibbs R. S. Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Obstet Gynecol. 1994 Dec;84(6):1058–1059. [PubMed] [Google Scholar]
- Berkowitz K., Regan J. A., Greenberg E. Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol. 1990 Jan;28(1):5–7. doi: 10.1128/jcm.28.1.5-7.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Betriu C., Gomez M., Sanchez A., Cruceyra A., Romero J., Picazo J. J. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother. 1994 Sep;38(9):2183–2186. doi: 10.1128/aac.38.9.2183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hillier S. L., Krohn M. A., Kiviat N. B., Watts D. H., Eschenbach D. A. Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):955–961. doi: 10.1016/0002-9378(91)90447-y. [DOI] [PubMed] [Google Scholar]
- McDuffie R. S., Jr, McGregor J. A., Gibbs R. S. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol. 1993 Oct;82(4 Pt 1):487–489. [PubMed] [Google Scholar]
- Mulder C. J., Bol P., Nabbe A. J., Zanen H. C. Susceptibility of 126 isolates of Escherichia coli from the cerebrospinal fluid of neonates to five antibiotics. J Antimicrob Chemother. 1985 Jan;15(1):115–118. doi: 10.1093/jac/15.1.115. [DOI] [PubMed] [Google Scholar]
- Pylipow M., Gaddis M., Kinney J. S. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics. 1994 Apr;93(4):631–635. [PubMed] [Google Scholar]
- Rouse D. J., Goldenberg R. L., Cliver S. P., Cutter G. R., Mennemeyer S. T., Fargason C. A., Jr Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol. 1994 Apr;83(4):483–494. doi: 10.1097/00006250-199404000-00001. [DOI] [PubMed] [Google Scholar]
- Schuchat A., Wenger J. D. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev. 1994;16(2):374–402. doi: 10.1093/oxfordjournals.epirev.a036159. [DOI] [PubMed] [Google Scholar]
- Tullus K., Berglund B., Burman L. G. Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime. Antimicrob Agents Chemother. 1990 Feb;34(2):361–362. doi: 10.1128/aac.34.2.361. [DOI] [PMC free article] [PubMed] [Google Scholar]